AMOT and breast carcinoma: In addition to the lipid metabolism markers, the MRD islets of patient 1016 also showed modulation of genes, such as AMOT, belonging to a dormancy signature previously identified in breast cancer (16) (Supplemental Figure 3B), suggesting the presence of a subpopulation of more quiescent cells within the captured MRD sample.